STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $450 | -17.7% | 42,300 | -35.6% | 0.00% | 0.0% |
| Q1 2023 | $547 | -43.3% | 65,700 | -37.2% | 0.00% | 0.0% |
| Q4 2022 | $965 | -99.9% | 104,600 | -17.5% | 0.00% | -50.0% |
| Q3 2022 | $1,628,000 | -19.9% | 126,800 | -17.6% | 0.00% | 0.0% |
| Q2 2022 | $2,033,000 | +697.3% | 153,900 | +1171.9% | 0.00% | – |
| Q1 2022 | $255,000 | -87.9% | 12,100 | -85.4% | 0.00% | -100.0% |
| Q3 2021 | $2,106,000 | -23.1% | 82,800 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $2,737,000 | +35.0% | 81,300 | +55.7% | 0.00% | 0.0% |
| Q1 2021 | $2,027,000 | – | 52,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |